Southeastern Diabetes Initiative Clinical Intervention (SEDI)
A Clinical Intervention to Serve High-Risk Patients in the Southeastern Diabetes Initiative and Durham Diabetes Coalition
Studieöversikt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljerad beskrivning
Clinical care will be delivered by a multidisciplinary team including (but not limited to) an physician, nurse practitioner, dietician, pharmacist, licensed clinical social worker (LCSW), case manager, health educator and a community health worker. Care will be delivered in community settings including home visits and community based clinics. With the exception of specific surveys (listed in the Study Intervention section) all data are being collected for the purpose of delivery of standard preventive care and clinical care. The population group will include patients diagnosed with Type 2 Diabetes Mellitus in four Southern United States counties, meeting certain inclusion criteria, and deemed "high risk" as determined by a set of standard criteria or a risk algorithm run on secondary data.
The investigators plan to characterize patients diagnosed or at risk for diabetes mellitus, and allow more detailed knowledge of their health than is provided by standard public health data. The investigators will use descriptive, parametric and non-parametric statistics to describe baseline characteristics (demographics and clinical measures of disease severity) of the sample and will compare responders and dropouts on independent and dependent variables, report any significant differences, and include this in the interpretation of results.
Studietyp
Studietyp
Inskrivning (Faktisk)
Inskrivning
Fas
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Mississippi
-
Madison, Mississippi, Förenta staterna
- Mississippi Public Health Institute
-
-
North Carolina
-
Durham, North Carolina, Förenta staterna
- Durham County Department of Public Health
-
Kannapolis, North Carolina, Förenta staterna
- Cabarrus Health Alliance
-
-
West Virginia
-
Williamson, West Virginia, Förenta staterna
- Williamson Health and Wellness Center
-
-
Deltagandekriterier
Urvalskriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Adults >=18yrs
- Diagnosis of Type 2 diabetes
- Reside in Durham County, NC, Cabarrus County, NC, Quitman County, MS or Mingo County, WV or the neighboring areas and receive the majority of their healthcare in the four listed counties.
- Have capacity to give consent (or have a surrogate legally authorized representative or caregiver provide consent on their behalf).
- Defined as high risk by the risk algorithm or their primary care clinician.
- Referral from the primary care clinician or patient's medical home if one has been designated.
Exclusion Criteria:
- Lack capacity to make decisions and do not have a surrogate with authority to make health care decisions.
- Have a terminal illness with a life expectancy of 6 months or less
- Diagnosis of Type 1 diabetes or gestational diabetes
- Currently pregnant (confirmed via self-report and/or medical record)
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Antal vapen
Vapen och interventioner
Deltagargrupp / ArmDeltagargrupp / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Experimentell: High Risk group
Extension of Care
|
Clinical care will be delivered by a multidisciplinary team including (but not limited to) a physician, nurse practitioner, dietitian, pharmacist, licensed clinical social worker (LCSW), case manager, health educator and a community health worker in community settings including home visits and community based clinics.
|
Vad mäter studien?
Primära resultatmått
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Mortality
Tidsram: Up to 24 months
|
Up to 24 months
|
Sekundära resultatmått
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Rate of health services utilization
Tidsram: up to 24 months
|
As measured by inpatient hospital admissions and emergency department visits
|
up to 24 months
|
|
Change in Medication Adherence
Tidsram: Baseline, 6, 12, 18, and 24 months
|
As measured by the Morisky Medication Adherence Score
|
Baseline, 6, 12, 18, and 24 months
|
|
Change in HbA1c
Tidsram: Baseline, 6, 12, 18, and 24 months
|
Baseline, 6, 12, 18, and 24 months
|
|
|
Change in blood lipids
Tidsram: Baseline, 6, 12, 18, and 24 months
|
Measurements include total cholesterol, HDL, LDL, triglycerides
|
Baseline, 6, 12, 18, and 24 months
|
|
Change in blood glucose
Tidsram: Baseline, 6, 12, 18, and 24 months
|
Baseline, 6, 12, 18, and 24 months
|
|
|
Change in blood pressure
Tidsram: Baseline, 6, 12, 18, and 24 months
|
Baseline, 6, 12, 18, and 24 months
|
|
|
Incidence of micro- and macro-vascular complications
Tidsram: Up to 24 months
|
Includes retinopathy, neuropathy, kidney disease, cardiovascular disease
|
Up to 24 months
|
|
Change in patient-reported outcomes
Tidsram: Baseline, 6, 12, 18, and 24 months
|
Includes results from PHQ 2, PAM-13, PROMIS 9, and REALM-SF surveys
|
Baseline, 6, 12, 18, and 24 months
|
Samarbetspartners och utredare
Sponsor
Sponsor
Samarbetspartners
Samarbetspartners
Utredare
Utredare
- Huvudutredare: Robert Califf, MD, Duke Translational Medicine Institute
- Huvudutredare: Bryan Batch, MD, Duke University
Studieavstämningsdatum
Studera stora datum
Studiestart
Studiestart
Primärt slutförande (Faktisk)
Primärt slutförande
Avslutad studie (Faktisk)
Avslutad studie
Studieregistreringsdatum
Först inskickad
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Första postat
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste uppdatering publicerad
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
Andra studie-ID-nummer
- Pro00043463
- 1C1CMS331018 (Annat bidrag/finansieringsnummer: Centers for Medicare and Medicaid Services)
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
produkt tillverkad i och exporterad från U.S.A.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .